Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

540 results

Filters applied: . Clear all
Page 1
Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.
Rajagopalan A, Aroori S, Russell TB, Labib PL, Ausania F, Pando E, Roberts KJ, Kausar A, Mavroeidis VK, Marangoni G, Thomasset SC, Frampton AE, Lykoudis P, Maglione M, Alhaboob N, Bari H, Smith AM, Spalding D, Srinivasan P, Davidson BR, Bhogal RH, Dominguez I, Thakkar R, Gomez D, Silva MA, Lapolla P, Mingoli A, Porcu A, Shah NS, Hamady ZZR, Al-Sarrieh B, Serrablo A, Croagh D; RAW Study Collaborators. Rajagopalan A, et al. Among authors: shah ns. HPB (Oxford). 2024 Apr 26:S1365-182X(24)01276-0. doi: 10.1016/j.hpb.2024.04.010. Online ahead of print. HPB (Oxford). 2024. PMID: 38755085
This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC). ...
This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduode …
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy.
Dreyzin A, Rankin AW, Luciani K, Gavrilova T, Shah NN. Dreyzin A, et al. Among authors: shah nn. Expert Rev Clin Immunol. 2024 May 14:1-19. doi: 10.1080/1744666X.2024.2349738. Online ahead of print. Expert Rev Clin Immunol. 2024. PMID: 38739466 Review.
Opportunities for improvement include development of new targets, optimally combining existing CAR T-cell therapies, and defining the role for adjunctive immune modulators and stem cell transplant in enhancing long-term survival....
Opportunities for improvement include development of new targets, optimally combining existing CAR T-cell therapies, and defining the role f …
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.
Pasquini MC, Wallace PK, Logan B, Kaur M, Tario JD, Howard A, Zhang Y, Brunstein C, Efebera Y, Geller N, Giralt S, Hari P, Horowitz MM, Koreth J, Krishnan A, Landau H, Somlo G, Shah N, Stadtmauer E, Vogl DT, Vesole DH, McCarthy PL, Hahn T. Pasquini MC, et al. Among authors: shah n. J Clin Oncol. 2024 May 3:JCO2300934. doi: 10.1200/JCO.23.00934. Online ahead of print. J Clin Oncol. 2024. PMID: 38701390
Serial MRD measurements may direct trials to test how further therapy may improve long-term PFS and OS....
Serial MRD measurements may direct trials to test how further therapy may improve long-term PFS and OS....
A rare case of retained metallic foreign body in liver: case report and review of literature.
Dev S, Yadav M, Shah NA, Dev B, Devkota S, Khadka L, Das DK, Yadav S, Sah JK, Ghimire B. Dev S, et al. Among authors: shah na. Ann Med Surg (Lond). 2024 Mar 21;86(5):3159-3164. doi: 10.1097/MS9.0000000000001992. eCollection 2024 May. Ann Med Surg (Lond). 2024. PMID: 38694309 Free PMC article.
Surgical removal remains the mainstay of the treatment. Long-term monitoring is crucial to detect potential complications, and imaging studies play a key role in regular follow-up. ...
Surgical removal remains the mainstay of the treatment. Long-term monitoring is crucial to detect potential complications, and imagin …
Infantile tremor syndrome with global developmental delay and microcephaly in a 16-month-old male: a case report.
Shah UK, Chaudhary S, Ghimire A, Shah N, Muskan V. Shah UK, et al. Among authors: shah n. Ann Med Surg (Lond). 2024 Apr 3;86(5):3180-3183. doi: 10.1097/MS9.0000000000002020. eCollection 2024 May. Ann Med Surg (Lond). 2024. PMID: 38694308 Free PMC article.
Despite neurological improvement with vitamin B12 supplementation, ITS's long-term impact on cognitive functions necessitates vigilance and appropriate nutritional interventions. CONCLUSION: Early recognition of ITS is vital for the prevention of long-term neurodeve …
Despite neurological improvement with vitamin B12 supplementation, ITS's long-term impact on cognitive functions necessitates vigilan …
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
Herring WL, Gallagher ME, Shah N, Morse KC, Mladsi D, Dong OM, Chawla A, Leiding JW, Zhang L, Paramore C, Andemariam B. Herring WL, et al. Among authors: shah n. Pharmacoeconomics. 2024 Apr 29. doi: 10.1007/s40273-024-01385-9. Online ahead of print. Pharmacoeconomics. 2024. PMID: 38684631
The predicted economic value of lovo-cel gene therapy was influenced by uncertainty in long-term clinical effects and by positive spillover effects on patient productivity and caregiver burden....
The predicted economic value of lovo-cel gene therapy was influenced by uncertainty in long-term clinical effects and by positive spi …
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757-8. Online ahead of print. Lancet. 2024. PMID: 38642570 Free article.
Age-standardised DALY rates due to injuries decreased globally by 24.0% (20.7-27.2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61.3 years (58.6-63.6) in 2010 to 62.2 years …
Age-standardised DALY rates due to injuries decreased globally by 24.0% (20.7-27.2) between 2010 and 2021, although improvements were not un …
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
Chanchlani N, Lin S, Bewshea C, Hamilton B, Thomas A, Smith R, Roberts C, Bishara M, Nice R, Lees CW, Sebastian S, Irving PM, Russell RK, McDonald TJ, Goodhand JR, Ahmad T, Kennedy NA; PANTS Consortium. Chanchlani N, et al. Lancet Gastroenterol Hepatol. 2024 Jun;9(6):521-538. doi: 10.1016/S2468-1253(24)00044-X. Epub 2024 Apr 16. Lancet Gastroenterol Hepatol. 2024. PMID: 38640937 Free article.
Low drug concentrations at the end of the induction period predict loss of response by year 3 of treatment, suggesting higher drug concentrations during the first year of treatment, particularly during induction, might lead to better long-term outcomes. Anti-drug antibodie …
Low drug concentrations at the end of the induction period predict loss of response by year 3 of treatment, suggesting higher drug concentra …
Hydroxyapatite ceramic-coated femoral components in younger patients followed up for 27 to 32 years.
Upadhyay PK, Shah N, Kumar V, Mirza SB. Upadhyay PK, et al. Among authors: shah n. Bone Jt Open. 2024 Apr 9;5(4):286-293. doi: 10.1302/2633-1462.54.BJO-2023-0136.R1. Bone Jt Open. 2024. PMID: 38591124 Free PMC article.
CONCLUSION: In young patients with high demands, the Furlong HAC-coated femoral component gives excellent long-term results....
CONCLUSION: In young patients with high demands, the Furlong HAC-coated femoral component gives excellent long-term results....
The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitors.
Furqan F, Shah NN. Furqan F, et al. Among authors: shah nn. Clin Adv Hematol Oncol. 2024 Apr;22(3):140-147. Clin Adv Hematol Oncol. 2024. PMID: 38588273 Review.
In addition, noncovalent BTK inhibitors have, for the first time, demonstrated efficacy in patients who progressed on other BTK inhibitors. Long-term data and comparative studies are needed to further investigate their efficacy and role in the landscape covalent BTK Inhibi …
In addition, noncovalent BTK inhibitors have, for the first time, demonstrated efficacy in patients who progressed on other BTK inhibitors. …
540 results